Association of helicobacter pylori infection with severity of coronary heart disease.

Background: There are few literatures evaluating the association between cytotoxin-associated gene A (CagA) positive strains of Helicobacter pylori (HP) and the severity of coronary heart disease (CHD). This study was designed to investigate this association.

Methods: Medical and drug history of 112 consecutive patients who were candidate for coronary angiography were taken.

Is helicobacter pylori infection a risk factor for coronary heart disease?

Background: There is still controversy about association of Helicobacter pylori (H. pylori) infection with coronary heart disease (CHD). This study designed to evaluate this association in a sample of Iranians Population.

Azithromycin effect on helicobacter pylori eradication: double blind randomized clinical trial.

Background/aims: To evaluate the efficacy of one- and two-week regimen of quadruple therapy containing azithromycin for Helicobacter pylori infection eradication.

Methodology: A total of 84 H. pylori-infected patients, were randomized into three groups: First group (n=31): 6 g AzOAB: Azithramycin 500 mg twice daily for 6 days and Omeprazole 20 mg, Amoxicillin 1 g, Bismuth 240 mg all twice daily for 2 weeks.